Evidence map›Paper›PMID 30904411›Full record

ArticleCurrent opinion in virology2019

Editorial overview: Emerging viruses: interspecies transmission: Expect the unexpected.

Adolfo García-Sastre, Juergen A Richt

Abstract readEditorial
In one paragraph

Article in Current opinion in virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Adolfo García-SastreIcahn School of Medicine at Mount Sinai, 1468 Madison Avenue, New York, NY 10029, USA. Electronic address: Adolfo.Garcia-Sastre@mssm.edu.
Juergen A RichtKansas State University, College of Veterinary Medicine, Diagnostic Medicine/Pathobiology, K-224B Mosier Hall, Manhattan, KS 66506-5601, USA. Electronic address: jricht@vet.k-state.edu.

Funding

Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KASARSKIS, ANDREW · 2015 to 2021
$46.6M
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)U19AI135972 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Adolfo Garcia-Sastre · 2018 to 2026
$27.2M
STRUCTURAL STUDIES IN THE CENTRAL NERVOUS SYSTEMP01AG000001 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 1985 to 2013
$20.7M
Toward a Universal Influenza Virus VaccineP01AI097092 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2012 to 2022
$17.6M
Project I: Immunity to Influenza in Primary Lung Epithelial CellsU19AI117873 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAYOT, FERNAND · 2015 to 2019
$8.6M
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza virusesR01AI141226 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2017 to 2023
$6.1M
Splicing and Nuclear Transport of Influenza Virus mRNAR01AI125524 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COBB, MELANIE H., FONTOURA, BEATRIZ MA · 2016 to 2025
$5.6M
Innate Immune Surveillance of HIV-1 During Transmission and Systemic InfectionR01AI127302 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI CHANDA, SUMIT K, GARCIA-SASTRE, ADOLFO · 2017 to 2021
$4.4M
Combination Adjuvants to Activate Human Dendritic Cell Subsets and B CellsU01AI124297 · NIAID · JACKSON LABORATORY · PI BANCHEREAU, JACQUES F · 2016 to 2020
$3.8M
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumorsR01CA229818 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI CHANDA, SUMIT K, GARCIA-SASTRE, ADOLFO · 2018 to 2021
$2.9M
ENDOTHELIAL CELL TROPISM IN THE PATHOGENESIS AND HOST RESPONSE AGAINST INFLUENZA VIRUSES - RESUBMISSION 01R01AI127775 · NIAID · UNIVERSITY OF IOWA · PI MANICASSAMY, BALAJI · 2018 to 2022
$2.8M
Novel vita-vaccine formula combines safety of dead and efficacy of live vaccinesR01AI127658 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLANDER, JULIE MAGARIAN · 2016 to 2020
$2.1M
NCI NIH HHS R01 CA229818NIAID NIH HHS HHSN272201400006CNIAID NIH HHS HHSN272201400008CNIAID NIH HHS P01 AI097092NIAID NIH HHS R01 AI125524NIAID NIH HHS R01 AI127302NIAID NIH HHS R01 AI127658NIAID NIH HHS R01 AI127775NIAID NIH HHS R01 AI141226NIAID NIH HHS R21 AI129486NIAID NIH HHS R21 AI142337NIAID NIH HHS R33 AI119304NIAID NIH HHS U01 AI124297NIAID NIH HHS U19 AI117873NIAID NIH HHS U19 AI118610NIAID NIH HHS U19 AI135972NIA NIH HHS P01 AG000001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCommunicable Diseases, EmergingHumansViral VaccinesVirus DiseasesVirusesZoonosesViral Vaccines

Identifiers

PMID30904411
PMCPMC7128631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.